Norwegian Adult Mental Health Registry
Launched by HELSE STAVANGER HF · Nov 1, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Norwegian Adult Mental Health Registry (NAMHR) is a study aimed at improving mental health care for adults in Norway. It collects information about patients dealing with conditions like depression, schizophrenia, bipolar disorder, and anxiety, among others. By gathering and organizing this data, the registry helps health professionals evaluate and enhance the treatment provided to these patients. If you are an adult living in Norway, aged 18 or older, and are receiving treatment for a mental health issue, you might be eligible to participate.
If you choose to take part, your information will be automatically included in the registry, but you can opt out at any time without affecting your treatment. This study is not currently recruiting participants yet, but it's designed to ensure that the care you receive is as effective as possible. Your involvement could contribute to better mental health services for everyone in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Residents in Norway aged 18 years or older assessed and granted right to treatment in specialized mental in- and out-patient settings
- Exclusion Criteria:
- • Persons who have reserved themselves against participation
- • Persons already included in more specialized register for mental disorder and/or treatment
About Helse Stavanger Hf
Helse Stavanger HF is a leading healthcare organization based in Norway, dedicated to providing high-quality medical services and advancing clinical research. As a prominent sponsor of clinical trials, Helse Stavanger HF focuses on innovative therapeutic interventions across various medical fields, aiming to enhance patient care and outcomes. With a commitment to ethical research practices and collaboration with academic institutions, the organization plays a vital role in the development of new treatments and the improvement of healthcare standards in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Inge Joa, PhD
Principal Investigator
Stavanger University hospital, Stavanger, Norway
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported